FDA Inspection 1326184 — Tahseen Mozaffar, M.D.
The FDA completed an inspection of Tahseen Mozaffar, M.D. on Jul 2, 2026 in Irvine, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 2, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Irvine, CA (United States)